5400
S.-S.P. Chou et al. / Tetrahedron 67 (2011) 5395e5401
1264, 1023, 752, 692 cmꢁ1; 1H NMR (CDCl3, 300 MHz)
d
7.37e7.25
(42), 57 (72), 55 (77), 43 (66), 41 (64); FAB-HRMS m/z calcd for
20H23NO3S2 389.1119, found 389.1122. Compound trans-18b:
white solid, mp 87e88 ꢀC; IR (ATR, film) 3538, 3057, 2976, 2932,
1636, 1598, 1475, 1371, 1266, 1164 cmꢁ1 1H NMR (CDCl3,
300 MHz)
(5H, m), 5.87 (1H, dd, J¼2.7, 6.0 Hz), 4.37 (1H, ddd, J¼3.0, 3.3,
C
18.9 Hz), 3.74e3.66 (2H, m), 2.45e2.09 (5H, m), 1.72e1.58 (1H, m);
13C NMR (CDCl3, 75 MHz)
d
174.1, 132.3, 131.9, 130.6, 129.3, 127.7,
;
124.4, 53.9, 41.2, 37.0, 29.9, 25.0; EI-MS (rel intensity) m/z 246 (Mþ1
,
d
7.69 (2H, d, J¼8.1 Hz), 7.31e7.21 (5H, m), 7.15e7.12
12), 245 (M, 97), 136 (100), 108 (20); EI-HRMS m/z calcd for
C14H15NOS 245.0874, found 245.0881.
(2H, m), 5.75 (1H, dd, J¼1.8, 2.7 Hz), 4.78e4.74 (1H, m), 4.07e3.98
(1H, m), 3.81e3.71 (1H, m), 3.66e3.58 (1H, m), 3.20 (1H, dd,
J¼4.8, 9.9 Hz), 2.47 (3H, s), 1.81 (1H, dd, J¼3.9, 17.4 Hz), 1.67 (1H,
ddt, J¼17.4, 10.2, 1.8 Hz), 1.36 (3H, d, J¼6.9 Hz); 13C NMR (CDCl3,
4.1.10. 7-(Phenylsulfonyl)-1,2,3,5,8,8a-hexahydro-3-indolizinone
(15). To a solution of compound 3 (100 mg, 0.41 mmol) in CH2Cl2
(3 mL) at 0 ꢀC was added dropwise another solution of mCPBA (50%
in H2O, 0.42 g, 1.22 mmol) in CH2Cl2 (3 mL). The reaction mixture
was stirred at 0 ꢀC for another 2 h, and was then diluted with more
CH2Cl2. The solution was washed with saturated aqueous sodium
thiosulfate, dried (MgSO4), and concentrated under reduced pres-
sure. The residue was purified by flash chromatography using ethyl
acetate/hexanes (1:2) as eluent to give compound 15 (89 mg, 79%)
as a light yellow oil: IR (ATR, film) 3065, 2972, 2884, 2838, 2250,
1762,1680,1645,1583,1446,1421,1367,1305,1289,1214,1197,1149,
75 MHz)
d
143.6, 139.0, 132.3, 131.9, 130.9, 129.7 (ꢂ2), 129.1, 127.6,
126.7, 62.7, 56.1, 53.9, 30.0, 21.5, 20.7.
4.1.13. cis-(E)- and (Z)-1-Tosyl-2-[(2-ethoxycarbonyl)ethenyl]-6-
methyl-4-(phenylthio)-1,2,3,6-tetrahydropyridine (19). Using a pro-
cedure similar to that for the preparation of 6, compound 18a
(100 mg, 0.26 mmol) gave product 19 (85 mg, 72%; E/Z¼8:1) as
a yellow liquid. The E/Z mixture could be recrystallized from
CH2Cl2/hexanes to give pure E-19 as
98.6e99.5 ꢀC; IR (ATR, film) 3055, 2987, 1717, 1656, 1600, 1266,
1163 cmꢁ1 1H NMR (CDCl3, 300 MHz)
a white solid: mp
1091, 1071, 1022, 998, 981, 910, 815, 756, 720, 688 cmꢁ1
(CDCl3)
;
1H NMR
;
d
7.68 (2H, d, J¼8.4 Hz),
d
7.87e7.84 (2H, m), 7.69e7.54 (3H, m), 7.04 (1H, dd, J¼5.7,
7.32e7.20 (7H, m), 6.85 (1H, dd, J¼5.1, 15.9 Hz), 5.83 (1H, dd, J¼1.8,
15.9 Hz), 5.75 (1H, dd, J¼2.4, 3.3 Hz), 4.78e4.74 (1H, m), 4.53e4.49
(1H, m), 4.20 (2H, q, J¼7.2 Hz), 2.45 (3H, s), 2.15e1.98 (2H, m), 1.37
(3H, d, J¼7.2 Hz), 1.30 (3H, t, J¼7.2 Hz); 13C NMR (CDCl3, 75 MHz)
2.7 Hz), 4.60 (1H, dt, J¼20.4, 3.3 Hz), 3.78e3.60 (2H, m), 2.70 (1H, d,
J¼14.1 Hz), 2.43e2.31 (3H, m), 2.04e1.93 (1H, m), 1.74e1.65 (1H,
m); 13C NMR (CDCl3)
d 174.1, 138.4, 138.3, 133.7, 133.3, 129.4, 128.1,
52.7, 40.2, 30.2, 29.5, 24.7; FABMS (rel intensity) m/z 278 (MþþH,
3), 147 (21), 119 (21), 105 (25), 95 (39), 81 (52), 69 (70), 55 (100), 41
(93); FAB-HRMS m/z calcd for C14H15NO3S 277.0695, found m/z
277.0689.
d
165.9, 146.6, 143.6, 137.5, 132.2 (ꢂ2), 129.9, 129.4, 129.1, 128.4,
127.9, 126.9, 123.0, 60.6, 50.9, 50.8, 30.4, 23.6, 21.6, 14.3; ESI-MS
(rel intensity) m/z 458 (MþþH, 26), 348 (70), 302 (71), 282
(100); ESI-HRMS m/z calcd for C24H27NO4S2 457.1367, found
457.1372.
4.1.11. cis- and trans-Ethyl 2-methyl-4-(phenylthio)-1-tosyl-1,2,5,6-
tetrahydro-6-pyridinecarboxylate (17). Using a procedure similar
to that for the preparation of 12, except that the reaction was carried
out in CF3CH2OH at room temperature for 12 h. Compound 16
(500 mg, 2.84 mmol) gave product 17 (906 mg, 74%) as an in-
separable liquid of cis/trans isomers (79:21): IR (film) 3055, 2980,
2933,1738,1597,1582,1475,1440,1338,1305,1196,1162,1100,1025,
4.1.14. cis-5-Methyl-7-(phenylthio)-1,2,3,5,8,8a-hexahydro-3-
indolizinone (20). Using a procedure similar to that for the prepa-
ration of 3, compound 19 (100 mg, 0.22 mmol) gave product 20
(40 mg, 70%) as a white solid: mp 112e114 ꢀC; IR (ATR, film) 3054,
2986, 2870, 1683, 1406, 1266 cmꢁ1 1H NMR (CDCl3, 300 MHz)
;
d
7.35e7.28 (5H, m), 5.84 (1H, dd, J¼2.4, 3.6 Hz), 4.19 (1H, br s), 3.59
958, 867, 745, 722, 692 cmꢁ1
;
13C NMR (CDCl3, 75 MHz)
d
170.4,170.3,
(1H, ddq, J¼2.1, 3.9, 6.0 Hz), 2.39e2.31 (3H, m), 2.25e2.11 (2H, m),
143.5, 143.3, 138.9, 137.4, 132.5 (ꢂ2), 132.0, 131.9, 131.7, 129.7, 129.4,
129.2, 129.1, 129.0, 128.8, 128.1, 127.7, 127.5, 127.1 (ꢂ2), 61.6, 61.5,
56.4, 52.8, 52.0, 50.7, 32.1, 29.1, 21.8 (ꢂ2), 21.5 (ꢂ2),14.0,13.9; EI-MS
(rel intensity) m/z 431 (Mþ, 0.39), 416 (12), 358 (16), 322 (12), 277
(14), 276 (100), 202 (42), 188 (29), 91 (28); EI-HRMS m/z calcd for
C22H25NO4S2 431.1225, found 431.1229. The cis-17 has some char-
1.62e1.52 (1H, m), 1.48 (3H, d, J¼6.6 Hz); 13C NMR (CDCl3, 75 MHz)
d
175.7, 133.2, 131.7, 131.6, 129.5, 129.3, 127.6, 56.9, 49.6, 36.7, 31.4,
26.4, 20.4; EI-MS (rel intensity) m/z 259 (20), 245 (17), 244 (100),
150 (94), 134 (19); EI-HRMS m/z calcd for C15H17NOS 259.1031,
found 259.1025. Anal. Calcd for C15H17NOS: C, 69.46; H, 6.61; N,
5.40; S, 12.36. Found: C, 69.36; H, 6.43; N, 5.33; S, 12.66.
acteristic absorptions: 1H NMR (CDCl3, 300 MHz)
d 7.70 (2H, d,
J¼8.4 Hz), 7.30e7.23 (7H, m), 5.73 (1H, t, J¼3.3 Hz), 4.84 (1H, dd,
J¼6.6, 1.5 Hz), 4.56e4.47 (1H, m), 4.22e4.11 (2H, m), 2.57 (1H, d,
J¼17.1 Hz), 2.42 (3H, s), 2.20e2.10 (1H, m),1.33 (3H, d, J¼7.2 Hz),1.19
(3H, t, J¼6.3 Hz). The trans-17 has some characteristic absorptions:
4.1.15. cis-5-Methyl-7-(phenylsulfonyl)-1,2,3,5,8,8a-hexahydro-3-
indolizinone (21). Using a procedure similar to that for the prepa-
ration of 15, compound 20 (100 mg, 0.39 mmol) gave product 21
(80 mg, 71%) as a white solid: mp 130.4e131.4 ꢀC; IR (ATR, film)
1H NMR (CDCl3, 300 MHz)
d
5.77 (1H, dd, J¼1.5, 2.1 Hz), 4.70 (1H, t,
3054, 2987, 2927, 1727, 1604, 1551, 1422, 1266 cmꢁ1
;
1H NMR
J¼4.9 Hz), 4.56e4.47 (1H, m), 4.22e4.11 (2H, m), 2.65e2.64 (2H, m),
1.27 (3H, d, J¼6.6 Hz), 1.21 (3H, t, J¼6.9 Hz).
(CDCl3, 300 MHz) d 7.88e7.86 (2H, m), 7.69e7.55 (3H, m), 6.96 (1H,
dd, J¼3.0, 3.6 Hz), 4.33 (1H, br s), 3.45 (1H, ddq, J¼2.4, 3.6, 6.6 Hz),
2.65 (1H, ddd, J¼15.9, 3.6,1.5 Hz), 2.40e2.31 (2H, m), 2.25e2.17 (1H,
m), 2.11e2.01 (1H, m), 1.66e1.51 (1H, m), 1.57 (3H, d, J¼6.6 Hz); 13C
4.1.12. 1-Tosyl-2-(hydroxymethyl)-6-methyl-4-(phenylthio)-1,2,3,6-
tetrahydropyridine (18). Using a procedure similar to that for the
preparation of 4, compound 17 (50 mg, 0.12 mmol) gave product
cis-18a (34 mg, 75%) and trans-18b (8 mg, 18%). Compound cis-
18a: white solid, mp 91.3e92.3 ꢀC; IR (ATR, film) 3533, 3055,
NMR (CDCl3, 75 MHz) d 175.7, 139.6, 138.7, 136.9, 133.8, 129.5, 128.1,
55.8, 49.0, 31.2, 30.6, 26.2, 19.0; EI-MS (rel intensity) m/z 291 (Mþ,
8), 276 (50), 150 (100), 125 (60), 84 (37), 67 (16), 17 (19); EI-HRMS
m/z calcd for C15H17NO3S 291.0929, found 291.0932.
2984, 2932, 1644, 1598, 1476, 1334, 1266, 1163 cmꢁ1
(CDCl3, 300 MHz)
;
1H NMR
d
7.67 (2H, d, J¼8.1 Hz), 7.31e7.17 (7H, m),
4.1.16. cis-5-Methyl-1,2,3,5,8,8a-hexahydro-3-indolizinone (22). To
a solution of compound 21 (40 mg, 0.14 mmol) in dried THF (4 mL)
was added 6% sodium amalgam (1.4 mmol) and two drops of
concentrated phosphoric acid. The mixture was heated at reflux
for 4 h. Upon cooling the mixture was filtered through Celite,
rinsed with ethyl acetate, and evaporated under vacuum. The
residue was purified by flash chromatography using ethyl acetate/
hexanes (1:2 to 1:1) to give product 22 (9 mg, 46%) as a colorless
5.77e5.75 (1H, m), 4.55e4.50 (1H, m), 4.09 (1H, tt, J¼7.8, 3.9 Hz),
3.66e3.59 (1H, m), 3.50e3.42 (1H, m), 2.45 (3H, s), 1.95 (1H, br s),
1.92e1.86 (2H, m), 1.44 (3H, d, J¼6.9 Hz); 13C NMR (CDCl3,
75 MHz)
d
143.7, 137.5, 132.6, 131.9, 130.0, 129.2, 128.7 (ꢂ2), 127.8,
126.9, 63.2, 52.9, 50.4, 28.0, 24.4, 21.7; FABMS (rel intensity) m/z
390 (MþþH, 18), 358 (40), 234 (54), 214 (85), 155 (41), 154 (100),
137 (58), 136 (100), 91 (82), 88 (44), 77 (52), 73 (43), 69 (60), 67